Healthcare

With a market capitalisation of approximately AUD 937.04 million, ARTRYA Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

With a market capitalisation of approximately AUD 438.39 million, Cogstate Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

With a market capitalisation of approximately AUD 1.94 billion, 4DMedical Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

Recce Pharmaceuticals disclosed that it had banked a cash refund of approximately A$3.67 million from the ATO. According to the company's disclosure, the payment is made up of about A$3.57 million relating to overseas research and development expenditure and a further A$95,826 in interest …

Key takeawaysShares in the company were trading up 10.26% at A$0.22 on 23 July 2026.The company's refined EXO-OC algorithm reported 92.5% sensitivity across all cancer stages at 98% specificity, up from a previously reported 77% sensitivity at 99.6% specificity, using its original 500-sample dataset.A …

Clarity Pharmaceuticals is a radiopharmaceutical company that designs targeted copper-based products, using its proprietary chelator technology, for imaging and treating cancer. Its most advanced asset is SAR-bisPSMA, which binds to prostate-specific membrane antigen (PSMA), a protein commonly over-expressed in prostate cancer cells. SAR-bisPSMA exists …

Osteopore Limited (ASX:OSX) has added another regulatory milestone to its Asian expansion after confirming that its neuro products have been approved for use at a major medical centre in Thailand. The approval builds on the company's previous regulatory progress in Hong Kong and mainland …